Staying Hopeful When the Odds of Surviving Cancer Are Long: A Follow-Up

Article

Why know the odds if they're useless?

A few weeks ago, I wrote an article in which I explained that odds were essentially meaningless for a specific person. I argued that the outcome was either going to happen or it wasn’t, and so the personal odds were either 100 percent or 0 percent. Since you didn’t know which of those two outcomes was going to happen to you personally, the odds were essentially useless. The trick to staying hopeful is to focus on living life and getting affairs in order in case there wasn’t much of it left.

So why know the odds at all? In fact, one of the leading breast oncologists I consulted for follow-up treatment for my own cancer refused to give me the information, saying that it would not affect my decision-making. I couldn’t disagree more strongly.

The first use of odds is to evaluate treatment options. Since almost all treatments have side effects and implications, you have the right to determine whether those consequences are worth the increased odds that treatment would provide. Not all physicians are interested in having you participate in the decision-making in that way, but without that information, you’re not able to participate in that way. As an example, I learned — but only with a great deal of persistence — that chemotherapy would reduce my likelihood of metastatic cancer by 2 to 3 percentage points. Given that my risk was starting at something less than 15 percent, this was simply not a significant enough risk reduction for me to suffer through the potential side effects of chemo. While that reduction was deemed significant enough to become the standard of care, it was simply not the care I wanted, given the tradeoffs. Without knowing the odds, though, and the effect of the proposed treatment on those odds, I wouldn’t have been able to make that decision.

The second use of odds is to set a context. I know I’ve said that odds don’t matter, but I think you live differently if you know you have a 5 percent chance of survival versus a 99 percent chance. We’re human, after all. Prudence would have us living the same way in both cases — most of us never know when we’re living our last day — and so we should be equally prepared. But the reality is that we’ll face our mortality more profoundly and deeply if it seems closer. Hope, though, still springs from truly and genuinely not knowing which group you’re in (the 100 percent or the 0 percent), and so you hope for the outcome you want ... and prepare. And again, I think it’s our right to have the context to use in whatever way we want.

Bottom line: Odds don’t have much to do with hope. Instead, odds help with practical decision making, both about our treatment options and being prepared, come what may.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content